· · · · · 

What’s Up With Women and HIV-Prevention Method PrEP?

The anti-retroviral drug Truvada, which is a combination of tenofovir and emtricitabine.

PrEP works when used properly. So why don’t women use it?

· · · · · 

The HIV Prevention Pill: How Is Truvada Taking Root in Black Communities?

In the months since the FDA’s approval of Truvada, some who work on prevention efforts in Black and low-income communities have urged PrEP proponents to pump their brakes.

· · · · · 

Sexual Health Roundup: HIV-Prevention Drug Wins FDA Panel Approval, Parents Talk About Internet Pornography

A New York Times article looks at how parents do (and should) react when their children inevitably see Internet pornography, an FDA advisory panel recommends approving a drug for HIV-prevention, and Massachusetts cuts over $1 million from its HIV-prevention and testing program in county jails. 

· · · · · 

Sexual Health Roundup: Promising Advances in HIV Prevention and Treatment; New Evidence on HPV, Cancer, and Vaccines

In this week’s sexual health roundup: scientists use engineered stem-cells to attack HIV; California tests a new pill that prevents HIV infection when taken daily but some question how expensive it is; the CDC releases alarming data on cancers caused by HPV in women; and South Carolina lawmakers take steps to increase HPV vaccination among middle school students.

· · · · ·